A Controlled Clinical Study To Evaluate The Effect Of Ashwagandha Churna In The Management Of Madhumeha w.s.r. To Diabetic Neuropathy - NI

Dr Ayush Dhankhar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Patients having cardinal symptoms of Madhumeha Upadrava like Daha, Harsha, Suptata and Shula will be selected.
•2.Diagnosed case of Type 2 Diabetic Neuropathy will be included.
•3.Mild to moderate Neuropathy patients having Toronto score between 6 to 11 will be included.
•4.Both fresh and treated cases will be included in the study.
•5.On-going oral hypoglycaemic agents will be continued during study.
•6.No other neuropathy managing drugs are allowed during study period.
•7.Patient who are willing to sign written consent will be included.

•1.IDDM (Type 1 DM) will be excluded from study.
•2.Diabetic patients with chronic alcoholism will be excluded.
•3.Pregnant and lactating women will be excluded.
•4.Patient with any other serious condition which have negative impact on the nerves like Meningitis/encephalitis/Polio etc. will be excluded.
•5.Patient having any other associated clinical condition like Dementia, Parkinson, Stroke which influence peripheral nerve function will be excluded.
•6.Patient having ulceration/infection of feet.
•7.Medical/Surgical condition limiting functional mobility.
•8.Non ambulatory patients.
•9.Patients who are not willing to participate / consent.

发起方

Dr Ayush Dhankhar